Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation1
- 31 May 2002
- journal article
- clinical trial
- Published by Elsevier
- Vol. 133 (5) , 657-664
- https://doi.org/10.1016/s0002-9394(02)01348-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- HISTOPATHOLOGIC CHANGES IN RETINOBLASTOMA AFTER CHEMOREDUCTIONRetina, 2000
- The Outcome of Chemoreduction Treatment in Patients With Reese-Ellsworth Group V RetinoblastomaArchives of Ophthalmology (1950), 1998
- Second nonocular tumors in survivors of bilateral retinoblastomaOphthalmology, 1998
- Alternative treatment in retinoblastomaOphthalmology, 1998
- Chemotherapy Plus Local Treatment in the Management of Intraocular RetinoblastomaArchives of Ophthalmology (1950), 1996
- Results of Combined Chemotherapy and Radiotherapy for Advanced Intraocular RetinoblastomaArchives of Ophthalmology (1950), 1996
- Chemoreduction in the Initial Management of Intraocular RetinoblastomaArchives of Ophthalmology (1950), 1996
- Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without RadiotherapyArchives of Ophthalmology (1950), 1996
- A New Era for the Treatment of RetinoblastomaArchives of Ophthalmology (1950), 1996
- Incidence of Second Neoplasms in Patients with Bilateral RetinoblastomaOphthalmology, 1988